Form 4: Director Fernando Aguirre Increases CVS Health Stake

CVS Health Director Fernando Aguirre acquired 1,563 shares of common stock as part of a semi-annual retainer payment.

Summary

• Director Fernando Aguirre acquired 1,563 shares of CVS Health common stock.
• The transaction occurred on May 14, 2026.
• The shares were issued at a price of $97.15 per share.
• The acquisition was made as payment for a semi-annual board retainer under the 2017 Incentive Compensation Plan.
• Following this transaction, the director's total beneficial ownership is 42,513 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director demonstrates alignment with shareholder interests through increased equity ownership.
• The acquisition reflects standard compensation practices for board members.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that director equity acquisitions via retainer plans are standard corporate governance practices, signaling confidence in the company's long-term trajectory without implying immediate market-moving news.

Comparison to Industry Standards

• The transaction aligns with standard S&P 500 corporate governance practices regarding director compensation.
• The use of equity-based retainers is consistent with industry peers like Walgreens Boots Alliance and Rite Aid.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation.

Key Dates

Keywords

CVS, CVS Health, Insider Trading, Form 4, Director Compensation, Equity Ownership